Celine Lomez
Gina
Search results
May 14, 2024 · The 2024 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee.
Through resources such as evidence-based strategy documents for asthma management, and events such as the annual celebration of World Asthma Day, GINA is working to improve the lives of people with asthma in every corner of the globe. LEARN MORE.
FAQs on the Genetic Information Nondiscrimination Act. Your Genetic Information and Your Health Plan - Know the Protections Against Discrimination. elaws Health Benefits Advisor. For Employers and Advisers. Topics. Workers. Employers and Advisers. Resources. Laws and Regulations.
Sep 9, 2014 · Title II of the Genetic Information Nondiscrimination Act (GINA) protects individuals against employment discrimination on the basis of genetic information. GINA covers employers with 15 or more employees, including state and local governments.
The Global Initiative for Asthma (GINA) is a medical guidelines organisation which works with public health officials and health care professionals globally to reduce asthma prevalence, morbidity, and mortality.
Dec 31, 2021 · The GINA Strategy Report provides clinicians with an annually updated evidence-based strategy for asthma management and prevention. This article summarizes key recommendations from GINA 2021, and the evidence underpinning the new changes. …
Jun 28, 2024 · The GINA 2024 asthma update includes new guidance on medications, monitoring, treatment goals, remission, cough variant asthma, children, and more.
Title II of the Genetic Information Nondiscrimination Act of 2008 (GINA), which prohibits genetic information discrimination in employment, took effect on November 21, 2009. Under Title II of GINA, it is illegal to discriminate against employees or applicants because of genetic information.
The Global Initiative for Asthma (GINA) aims to improve the diagnosis, management, and prevention of asthma by providing an up-to-date evidence-based strategy and tools and practical resources for clinicians worldwide.
The GINA strategy has a strong focus on preventing asthma-related deaths and severe exacerbations, as well as on efficacy and effectiveness for symptom control and lung function, and it promotes personalised treatment decisions across the spectrum of asthma severity.
